NCT06745882 - Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC | Biotech Hunter

Enrollment

318

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Cisplatin

Given on day 1 of every 21-day cycle.

DRUG

Carboplatin

Given on day 1 of every 21-day cycle.

DRUG

Pemetrexed

Given on day 1 of every 21-day cycle.

DRUG

Pembrolizumab

Given on day 1 of every 21-day cycle. After cycle 4 is given every 6 weeks.

DRUG

Abraxane

Given on days 1, 8, and 15 of each 21-day cycle.

DRUG

Paclitaxel

Given on day 1 of every 21-day cycle.

Trial Locations (1)

RECRUITING

Moffitt Cancer Center, Tampa